Topics

Treating COVID-19—Off-Label and Compassionate Use and Clinical Trials During Pandemics

20:00 EDT 23 Mar 2020 | JAMA

This Viewpoint uses the absence of known effective treatment for Ebola virus disease to emphasize the costs of off-label and compassionate drug use during an infectious disease outbreak and the importance of establishing the efficacy and safety of promising drug leads in randomized trials to inform their clinical use.

Original Article: Treating COVID-19—Off-Label and Compassionate Use and Clinical Trials During Pandemics

NEXT ARTICLE

More From BioPortfolio on "Treating COVID-19—Off-Label and Compassionate Use and Clinical Trials During Pandemics"

Quick Search

Relevant Topics

Marburg and Ebola Virus Infections
Ebola virus and Marburg virus are related viruses that cause hemorrhagic fevers — illnesses marked by severe bleeding (hemorrhage), organ failure and, in many cases, death. Both viruses are native to Africa, where sporadic outbreaks have occurred f...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Infectious-diseases
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...